These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2161508)

  • 1. Viral vaccines of the future.
    Gershon AA
    Pediatr Clin North Am; 1990 Jun; 37(3):689-707. PubMed ID: 2161508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live attenuated varicella vaccine: protection in healthy adults compared with leukemic children. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group.
    Gershon AA; Steinberg SP
    J Infect Dis; 1990 Apr; 161(4):661-6. PubMed ID: 2156941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varicella vaccine: the American experience.
    Gershon AA; LaRussa P; Hardy I; Steinberg S; Silverstein S
    J Infect Dis; 1992 Aug; 166 Suppl 1():S63-8. PubMed ID: 1320652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of healthy adults with live attenuated varicella vaccine.
    Gershon AA; Steinberg SP; LaRussa P; Ferrara A; Hammerschlag M; Gelb L
    J Infect Dis; 1988 Jul; 158(1):132-7. PubMed ID: 2839577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live attenuated varicella vaccine use in immunocompromised children and adults.
    Gershon AA; Steinberg SP; Gelb L
    Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects for use of a varicella vaccine in adults.
    Hardy IR; Gershon AA
    Infect Dis Clin North Am; 1990 Mar; 4(1):159-73. PubMed ID: 2155261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varicella-zoster virus: prospects for control.
    Gershon AA
    Adv Pediatr Infect Dis; 1995; 10():93-124. PubMed ID: 7718215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immune responses after immunization of healthy seronegative children with varicella vaccine: kinetics and specificity.
    Watson B; Keller PM; Ellis RW; Starr SE
    J Infect Dis; 1990 Oct; 162(4):794-9. PubMed ID: 2169495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live attenuated varicella vaccine.
    Gershon AA
    Annu Rev Med; 1987; 38():41-50. PubMed ID: 3034136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
    Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A
    Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine.
    Watson B; Gupta R; Randall T; Starr S
    J Infect Dis; 1994 Jan; 169(1):197-9. PubMed ID: 8277182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
    Hardy I; Gershon AA; Steinberg SP; LaRussa P
    N Engl J Med; 1991 Nov; 325(22):1545-50. PubMed ID: 1658650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and treatment of VZV infections in patients with HIV.
    Gershon AA
    Herpes; 2001 Jul; 8(2):32-6. PubMed ID: 11867015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status and prospects of live varicella vaccine.
    Takahashi M
    Vaccine; 1992; 10(14):1007-14. PubMed ID: 1335196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine.
    Nader S; Bergen R; Sharp M; Arvin AM
    J Infect Dis; 1995 Jan; 171(1):13-7. PubMed ID: 7798653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine.
    Diaz PS; Smith S; Hunter E; Arvin AM
    J Infect Dis; 1988 Dec; 158(6):1245-52. PubMed ID: 2848901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immune responses to live attenuated varicella vaccine.
    Gershon AA
    Rev Infect Dis; 1991; 13 Suppl 11():S957-9. PubMed ID: 1664134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspective on live varicella vaccine.
    Gershon AA; Katz SL
    J Infect Dis; 2008 Mar; 197 Suppl 2():S242-5. PubMed ID: 18419404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
    Diaz PS; Smith S; Hunter E; Arvin AM
    J Immunol; 1989 Jan; 142(2):636-41. PubMed ID: 2536059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine.
    Gershon AA; Steinberg SP
    N Engl J Med; 1989 Apr; 320(14):892-7. PubMed ID: 2538749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.